Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Critical Appraisal of Evidence for Improving Gait Speed in People with Multiple Sclerosis: Dalfampridine Versus Gait Training.
Population PK-PD Analyses of CD25 Occupancy, CD56(bright) NK Cell Expansion, and Regulatory T Cell Reduction by Daclizumab HYP in Subjects with Multiple Sclerosis.
Longitudinally extensive transverse myelitis: A retrospective analysis of sixty-four patients at tertiary care center of North-West India.
Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls.
Determinants of non-adherence to disease-modifying therapies in multiple sclerosis: A cross-Canada prospective study.
Discovery and structural optimization of 4-(4-(benzyloxy)phenyl)-3,4-dihydropyrimidin-2(1H)-ones as RORc inverse agonists.
Novel molecular insights into the critical role of sulfatide in myelin maintenance/function.
Iron uptake and transport across physiological barriers.
Imaging in multiple sclerosis: A new spin on lesions.
Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis.
Interleukin 17 alone is not a discriminant biomarker in early demyelinating spectrum disorders.
Commentary on painful tonic spasms and brainstem involvement in a patient with neuromyelitis optica spectrum disorder.
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients.
Role of genetic susceptibility variants in predicting clinical course in multiple sclerosis: a cohort study.
Erratum to: The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach.
Clinical Features of Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders.
Tuning PAK Activity to Rescue Abnormal Myelin Permeability in HNPP.
Automated multi-objective calibration of biological agent-based simulations.
Glial Cells and Integrity of the Nervous System.
Management of bladder dysfnction in patients with multiple sclerosis.
Non-Gaussian Diffusion Imaging Shows Brain Myelin and Axonal Changes in Obstructive Sleep Apnea.
Decrease in rate of multiple sclerosis-related hospitalizations in Portugal.
Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon β-1a in MS.
Relationship of grey and white matter abnormalities with distance from the surface of the brain in multiple sclerosis.
[Monoclonal antibodies, overview and outlook of a promising therapeutic option].

Pages